Active Biotech AB (STU:BTP) Moat Score: 0/10 (As of Jun. 26, 2026)


STU:BTP Active Biotech AB STU:BTP
30 GF Score
Price €0.50
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB Moat Score?

Active Biotech AB has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Active Biotech AB has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Active Biotech AB might have No Moat - No discernible moat.

Active Biotech AB  (STU:BTP) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Active Biotech AB Moat Score Related Terms

STU:BTP
30GF Score
Active Biotech AB STU:BTP
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB Business Description

Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
30GF Score

Get the complete analysis for STU:BTP

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price